Full Text
Biologic Brands and Biosimilars for Rheumatoid Arthritis In The Eu5- Contention For Cost-Effectiveness

Abstract

Authors

J. Cox C. Stanton

Back to Volume 18, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×